How does G3O's PS Ratio compare to its peers?

G3O is good value based on its Price-To-Sales Ratio (1.9x) compared to the peer average (2x).

How does G3O's PS Ratio compare vs other companies in the DE Medical Equipment Industry?

G3O is good value based on its Price-To-Sales Ratio (1.9x) compared to the European Medical Equipment industry average (3.6x).

What is G3O's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

G3O is expensive based on its Price-To-Sales Ratio (1.9x) compared to the estimated Fair Price-To-Sales Ratio (1.3x).

What is the Fair Price of G3O when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate G3O's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

S.M.A.I.O DB:G3O Stock Report

Last Price

€2.39

Market Cap

€13.1m

7D

1.7%

1Y

-5.9%

Updated

22 Dec, 2024

Data

Company Financials +

S.M.A.I.O S.A.

DB:G3O Stock Report

Market Cap: €13.1m

G3O Stock Overview

Provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery. More details

G3O fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	5/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Rewards

Earnings are forecast to grow 103.82% per year

Earnings have grown 36.3% per year over the past 5 years

Risk Analysis

Does not have a meaningful market cap (€13M)

My Notes

Capture your thoughts, links and company narrative

S.M.A.I.O S.A. Competitors

aap Implantate

XTRA:AAQ1

€15.6m

Geratherm Medical

XTRA:GME

€18.4m

Audientes

DB:AUG

€6.9m

PULSION Medical Systems

MUN:PUS

€133.6m

Price History & Performance

Summary of share price highs, lows and changes for S.M.A.I.O
Historical stock prices
Current Share Price	€2.39
52 Week High	€4.24
52 Week Low	€2.23
Beta	0.65
1 Month Change	0.42%
3 Month Change	-38.56%
1 Year Change	-5.91%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-39.34%

Recent News & Updates

Recent updates

Shareholder Returns

	G3O	DE Medical Equipment	DE Market
7D	1.7%	-2.9%	-2.6%
1Y	-5.9%	-8.5%	6.9%

Return vs Industry: G3O exceeded the German Medical Equipment industry which returned -8.5% over the past year.

Return vs Market: G3O underperformed the German Market which returned 6.9% over the past year.

Price Volatility

Is G3O's price volatile compared to industry and market?
G3O volatility
G3O Average Weekly Movement	6.1%
Medical Equipment Industry Average Movement	6.6%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	11.2%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: G3O has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: G3O's weekly volatility (6%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2009	43	Philippe Roussouly	smaio.com

S.M.A.I.O S.A. provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery. The company was incorporated in 2009 and is based in Saint-Priest, France.

S.M.A.I.O S.A. Fundamentals Summary

How do S.M.A.I.O's earnings and revenue compare to its market cap?
G3O fundamental statistics
Market cap	€13.14m
Earnings (TTM)	-€1.24m
Revenue (TTM)	€6.80m

1.9x

P/S Ratio

-10.6x

P/E Ratio

Is G3O overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
G3O income statement (TTM)
Revenue	€6.80m
Cost of Revenue	€3.51m
Gross Profit	€3.28m
Other Expenses	€4.52m
Earnings	-€1.24m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Apr 15, 2025

Earnings per share (EPS)	-0.24
Gross Margin	48.29%
Net Profit Margin	-18.28%
Debt/Equity Ratio	34.0%

How did G3O perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 17:27
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

S.M.A.I.O S.A. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Claire Deray	TPICAP Midcap